EDITION:
- EU
- NA
Pre-clinical-stage pharmaceutical company MIRA Pharmaceuticals, has launched on the NASDAQ, with shares trading from 3 August 2023 under the symbol
MGC Pharmaceuticals MGC Pharmaceuticals released a flurry of updates over the last week, announcing plans to launch a A$2.7m
Cantourage German-listed cannabis distributor Cantourage informed investors this week that it expects to see ‘double digit’ sales growth and
Incannex has announced it will be relocating to Delaware, United States from Australia. A newly formed Delaware corporation called Incannex
After announcing its intentions to do so in May 2023, Curaleaf has now confirmed it aims to list subordinate voting
Oxford Cannabinoid Technologies Oxford Cannabinoid Technologies announced this week that it had identified a potential ‘first in class’ immunotherapy
Cellular Goods Cellular Goods has issued a long-awaited update to investors regarding its recent acquisition of carbon sequestration company
Ananda Developments Aquis Stock Exchange-listed Ananda Developments has seen its stock jump by nearly 20% over the last week following
The embattled cannabis giant announced this week that it was undertaking several moves to improve its liquidity and pay down
North American cannabis operator TerrAscend is set to see its shares listed on the Toronto Stock Exchange (TSX) next week.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
